Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Oesophagogastric Cancer × Bevacizumab × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 422 Carcinoma, Hepatocellular 106 Rectal Neoplasms 104 Colonic Neoplasms 101 Neoplasm Metastasis 59 Pancreatic Neoplasms 50 Liver Neoplasms 37 Neoplasms 35 Stomach Neoplasms 34 Esophageal Neoplasms 21 Carcinoma, Non-Small-Cell Lung 19 Colorectal Cancer Metastatic 18 Ovarian Neoplasms 13 Gastrointestinal Neoplasms 12 Breast Neoplasms 12 Biliary Tract Neoplasms 10 Adenocarcinoma 10 Digestive System Neoplasms 9 Carcinoma, Renal Cell 9 Lung Neoplasms 8 Cholangiocarcinoma 8 Melanoma 7 Intestinal Neoplasms 7 Gallbladder Neoplasms 7 Triple Negative Breast Neoplasms 5 Sarcoma 5 Glioblastoma 5 Esophageal Squamous Cell Carcinoma 5 Endometrial Neoplasms 5 Uterine Cervical Neoplasms 4

Interventions

Neoadjuvant Therapy 1 Lapatinib 1 Epirubicin 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Capecitabine 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00450203 2016-12-01

ST03

Medical Research Council

Phase 2/3 Unknown

Gastrointestinal

Oesophagogastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡